Open Access
| Issue |
E3S Web Conf.
Volume 271, 2021
2021 2nd International Academic Conference on Energy Conservation, Environmental Protection and Energy Science (ICEPE 2021)
|
|
|---|---|---|
| Article Number | 03023 | |
| Number of page(s) | 4 | |
| Section | Research on Energy Chemistry and Chemical Simulation Performance | |
| DOI | https://doi.org/10.1051/e3sconf/202127103023 | |
| Published online | 15 June 2021 | |
- Zhu Limei, Li Xianli. Research progress on the mechanism of hyperuricemia leading to abnormal glucose metabolism [J]. Medical review, 2019, 25 (22): 4509–4514. [Google Scholar]
- Zhao Hongjing, Yang Yanlang, Ye Yinyin, et al. Research progress of febuxostat in the treatment of hyperuricemia [J]. Anhui Medical Journal, 2018, 39 (2): 239–241. [Google Scholar]
- Lei Sanxia. Research progress on correlation between hyperuricemia and kidney damage [J]. Medical review, 2014, 20 (10): 1775–1777. [Google Scholar]
- Wang Hongyun. Research progress on pathogenesis of kidney damage in chronic hyperuricemia [J]. International Journal of Urology, 2011, 31 (1): 109112. [Google Scholar]
- Wang Yahua, Wang Yaping. Research progress of kidney damage in hyperuricemia [J]. Chinese Journal of evidence based cardiovascular medicine, 2013, 5 (1): 91–92. [Google Scholar]
- Wen Wen, Li Yuehong, Mu Rong. Research progress of kidney damage in hyperuricemia [J]. Journal of clinical internal medicine, 2016, 33 (5): 309–311. [Google Scholar]
- Huang Weiyuan. Efficacy observation and analysis of irbesartan plus amlodipine besylate in the treatment of elderly diabetes mellitus with hypertension and hyperuricemia [J]. Chinese Journal of practical medicine, 2020, 15 (2): 117–119. [Google Scholar]
- Wang Tian, Chen Tao, Cai Qi, et al. Efficacy of febuxostat combined with potassium citrate sustained release tablets in the treatment of gout and hyperuricemia with kidney calculi [J]. Journal of practical medicine, 2020,36 (2): 224–228. [Google Scholar]
- Yin Xianglin, Yao Songpo, Li Xingzhou, et al. Risk factors of gout and hyperuricemia [J]. Chinese Journal of Gerontology, 2020,40 (10): 2041–2044. [Google Scholar]
- Zhang Jingwen, Wang Ning, Qiu Hongxia, et al. Effect of febuxostat on kidney function in patients with early diabetic nephropathy complicated with hyperuricemia [J]. Shaanxi medical journal, 2020,49 (2): 209–211, 230. [Google Scholar]
- Xiao Xiaoqin, Chen Shangru, Yao Chun, et al. A practical study on the intervention of multidisciplinary diet and exercise management in patients with hyperuricemia [J]. Chinese and foreign medical research, 2020,18(1): 158–160. [Google Scholar]
- Liu Yuanhao. Clinical efficacy of Niaoduqing Granules Combined with febuxostat tablets in the treatment of hypertensive nephropathy with hyperuricemia [J]. Modern hospital, 2020,20 (3): 427–430 434. [Google Scholar]
- Dai Yuanhui, Hao Yuqi. Predictive significance of hyperuricemia for contrast induced nephropathy in ACS patients with normal kidney function after PCI [J]. Chongqing Medical Journal, 2020,49 (20): 3427–3430. [Google Scholar]
- Xiao Ni Shao, Mei Wei Wu, Ya Nan Hei, et al. Metabonomics of urine and kidney in rats with chronic hyperuricemic nephropathy [J]. Chinese Pharmacological Bulletin, 2020,36 (11): 1607–1614. [Google Scholar]
- Lu Zhenzhen, Deng Yueyi, Liu Wangyi. Correlation between hyperuricemia and IgA nephropathy in kidney biopsy [J]. Journal of Anhui Medical University, 2020,55 (3): 456–460. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.